This undiscovered CBD play is on the verge of disrupting the industry
With recent health Canada approval they are poised to explode
Read more here

EXEL Insider Trading (Exelixis)

Insider Ownership Percentage: 4.50%
Insider Buying (Last 12 Months): $0.00
Insider Selling (Last 12 Months): $29,959,887.24

Exelixis Insider Trading History Chart

Exelixis Share Price & Price History

$22.66
▲ +0.45 (2.03%)
As of 02/24/2021 01:00 AM ET
Days: 30 | 90 | 365
Are you looking for the next great pet stock play?
Don't miss this opportunity as FRPT is already trading over 100 dollars per share!
Read more here about the next great pet stock!

Exelixis Insider Trading History

Transaction DateInsider NameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionShares Held After TransactionDetails
2/22/2021Vincent T. MarchesiDirectorSell24,097$22.29$537,122.13424,415  
2/17/2021Gisela SchwabCMOSell50,000$22.50$1,125,000.00  
2/16/2021Carl B FeldbaumDirectorSell20,000$21.96$439,200.0028,521  
2/12/2021Patrick J. HaleyEVPSell45,000$21.57$970,650.00  
2/1/2021Peter LambEVPSell65,000$22.08$1,435,200.00  
1/12/2021Christopher J. SennerCFOSell30,000$25.00$750,000.00  
1/4/2021Peter LambEVPSell65,000$20.32$1,320,800.00  
12/18/2020Peter LambEVPSell65,000$20.01$1,300,650.00  
11/24/2020Vincent T. MarchesiDirectorSell40,004$18.50$740,074.00  
11/10/2020Jack L. WyszomierskiDirectorSell34,000$20.61$700,740.00  
10/21/2020Jeffrey HessekielEVPSell39,742$21.95$872,336.90  
10/8/2020Christopher J. SennerCFOSell10,000$25.00$250,000.00  
9/21/2020Patrick J. HaleyEVPSell4,680$26.09$122,101.20  
9/15/2020Christopher J. SennerCFOSell20,000$25.00$500,000.00  
7/20/2020Patrick J. HaleyEVPSell3,151$25.36$79,909.36  
6/8/2020Peter LambEVPSell26,000$22.56$586,560.00  
6/4/2020Gisela SchwabCMOSell100,000$22.96$2,296,000.00  
5/21/2020Vincent T. MarchesiDirectorSell40,000$24.64$985,600.0012,718  
5/20/2020Patrick J. HaleyEVPSell3,151$24.99$78,743.49  
5/18/2020Lance WillseyDirectorSell30,000$26.26$787,800.00398,273  
5/14/2020Lance WillseyDirectorSell15,000$25.26$378,900.00383,273  
5/11/2020Jeffrey HessekielEVPSell38,006$27.09$1,029,582.54  
5/11/2020Vincent T. MarchesiDirectorSell30,000$26.30$789,000.00  
5/8/2020Patrick J. HaleyEVPSell21,375$25.87$552,971.25  
5/8/2020Stelios PapadopoulosDirectorSell45,000$25.84$1,162,800.00  
5/7/2020Christopher J. SennerCFOSell21,417$25.80$552,558.60  
4/24/2020George A ScangosDirectorSell15,000$26.24$393,600.00808,731  
4/23/2020Gisela SchwabCMOSell100,000$26.00$2,600,000.00  
4/23/2020Patrick J. HaleyEVPSell5,000$26.00$130,000.00  
4/22/2020George A ScangosDirectorSell4,200$25.05$105,210.00894,531  
4/20/2020George A ScangosDirectorSell50,000$23.89$1,194,500.00894,531  
4/20/2020Patrick J. HaleyEVPSell5,000$24.00$120,000.00  
4/15/2020George A ScangosDirectorSell25,000$18.31$457,750.00913,031  
4/7/2020George A ScangosDirectorSell16,435$18.25$299,938.75945,096  
4/6/2020Peter LambEVPSell50,000$17.26$863,000.00  
4/3/2020Jack L. WyszomierskiDirectorSell13,848$16.57$229,461.36  
3/31/2020George A ScangosDirectorSell1,500$18.06$27,090.00961,531  
3/20/2020Patrick J. HaleyEVPSell4,318$15.37$66,367.66  
3/4/2020Gisela SchwabCMOSell100,000$19.40$1,940,000.00  
3/3/2020Carl B FeldbaumDirectorSell38,000$18.84$715,920.0040,521  
2/26/2020Michael MorrisseyCEOSell25,000$18.91$472,750.00  
2/19/2020Gisela SchwabCMOSell40,000$21.50$860,000.00  
2/19/2020Michael MorrisseyCEOSell25,000$21.75$543,750.00  
2/19/2020Patrick J. HaleyEVPSell5,000$22.00$110,000.00  
2/18/2020George A ScangosDirectorSell50,000$20.73$1,036,500.00963,031  
2/14/2020Alan M GarberDirectorSell12,500$21.02$262,750.0048,829  
2/13/2020Michael MorrisseyCEOSell25,000$20.11$502,750.00  
2/11/2020George A ScangosDirectorSell4,000$20.14$80,560.001,034,031  
2/7/2020Gisela SchwabCMOSell50,000$18.37$918,500.00  
1/29/2020Michael MorrisseyCEOSell25,000$17.87$446,750.00  
1/23/2020Michael MorrisseyCEOSell25,000$19.41$485,250.001,038,031  
1/16/2020Michael MorrisseyCEOSell25,000$20.33$508,250.00  
1/15/2020Vincent T. MarchesiDirectorSell61,683$20.01$1,234,276.83  
1/8/2020Michael MorrisseyCEOSell25,000$18.85$471,250.00  
1/7/2020Alan M GarberDirectorSell86,956$18.01$1,566,077.5691,329  
1/7/2020Gisela SchwabCMOSell50,000$17.96$898,000.00  
1/2/2020Michael MorrisseyCEOSell25,000$17.49$437,250.00  
12/3/2019Gisela SchwabCMOSell50,000$17.36$868,000.00
11/4/2019Gisela SchwabCMOSell50,000$15.99$799,500.00  
10/10/2019Patrick J. HaleyVPSell303$16.27$4,929.81  
10/2/2019Michael MorrisseyCEOSell26,364$17.66$465,588.24  
10/1/2019Gisela SchwabCMOSell30,000$17.87$536,100.00  
9/18/2019Michael MorrisseyCEOSell37,227$19.20$714,758.40  
9/10/2019Patrick J. HaleyVPSell1,000$18.84$18,840.00  
8/16/2019George PosteDirectorSell25,000$20.50$512,500.00  
8/16/2019Jeffrey HessekielEVPSell75,000$21.10$1,582,500.00  
8/14/2019Michael MorrisseyCEOSell35,040$20.11$704,654.40  
8/12/2019Patrick J. HaleyVPSell1,000$20.39$20,390.00  
8/9/2019George PosteDirectorSell20,000$20.60$412,000.00  
8/6/2019Patrick J. HaleyInsiderSell25,000$20.02$500,500.00  
8/2/2019Michael MorrisseyInsiderSell35,040$20.25$709,560.00  
8/1/2019George A ScangosDirectorSell40,000$20.59$823,600.001,134,081  
7/17/2019Michael MorrisseyCEOSell34,721$21.37$741,987.77  
7/10/2019Patrick J. HaleyInsiderSell1,000$20.96$20,960.00  
7/3/2019Michael MorrisseyCEOSell34,721$21.03$730,182.63  
7/1/2019George A ScangosDirectorSell40,000$21.58$863,200.001,168,031  
6/17/2019Peter LambEVPSell217,404$20.59$4,476,348.36  
6/13/2019Peter LambEVPSell27,596$20.03$552,747.88  
6/10/2019Patrick J. HaleyInsiderSell1,000$20.23$20,230.00  
6/4/2019George A ScangosDirectorSell40,000$19.76$790,400.001,223,031  
5/10/2019Patrick J. HaleyInsiderSell1,000$19.58$19,580.00  
5/8/2019Lance WillseyDirectorSell50,000$20.36$1,018,000.00368,273  
5/8/2019Michael MorrisseyInsiderSell42,000$20.15$846,300.00  
5/3/2019Christopher J. SennerCFOSell36,261$20.70$750,602.70  
5/2/2019George A ScangosDirectorSell40,000$19.84$793,600.001,248,031  
4/24/2019Michael MorrisseyInsiderSell40,000$20.75$830,000.00  
4/10/2019Michael MorrisseyInsiderSell40,000$24.06$962,400.00  
4/10/2019Patrick J. HaleyVPSell1,000$24.04$24,040.00  
4/3/2019George A ScangosDirectorSell5,000$25.03$125,150.001,278,031  
4/3/2019Gisela SchwabInsiderSell63,109$25.00$1,577,725.00  
4/1/2019Alan M GarberDirectorSell30,000$23.99$719,700.0076,329  
4/1/2019Jeffrey HessekielEVPSell20,000$24.03$480,600.00  
3/29/2019George PosteDirectorSell3,860$23.89$92,215.40  
3/27/2019Michael MorrisseyCEOSell40,000$23.39$935,600.00  
3/26/2019Patrick J. HaleyInsiderSell2,700$23.47$63,369.00  
3/25/2019Gisela SchwabCMOSell100,000$23.14$2,314,000.00  
3/14/2019George A ScangosDirectorSell5,000$25.00$125,000.001,318,031  
3/14/2019Patrick J. HaleyInsiderSell2,000$25.00$50,000.00  
3/13/2019Michael MorrisseyCEOSell40,000$24.64$985,600.00  
3/11/2019Patrick J. HaleyVPSell959$23.13$22,181.67  
3/1/2019George A ScangosDirectorSell40,000$22.66$906,400.001,323,031  
2/27/2019Michael MorrisseyCEOSell40,000$22.69$907,600.00  
2/25/2019Charles CohenDirectorSell5,271$22.18$116,910.7811,250  
2/25/2019Patrick J. HaleyInsiderSell4,272$22.27$95,137.44  
2/22/2019Vincent T. MarchesiDirectorSell41,250$21.50$886,875.00  
2/19/2019Charles CohenDirectorSell248,180$22.14$5,494,705.20148,180  
2/14/2019Carl B FeldbaumDirectorSell50,500$22.03$1,112,515.0030,221  
2/14/2019Gisela SchwabCMOSell100,000$21.66$2,166,000.00148,180  
2/14/2019Michael MorrisseyCEOSell40,000$22.39$895,600.00  
2/11/2019Patrick J. HaleyInsiderSell1,000$21.30$21,300.00  
2/1/2019George A ScangosDirectorSell40,000$23.53$941,200.001,363,031  
1/30/2019Michael MorrisseyInsiderSell40,000$23.12$924,800.00  
1/16/2019Michael MorrisseyInsiderSell40,000$23.29$931,600.00  
1/9/2019Patrick J. HaleyInsiderSell9,120$22.18$202,281.60  
1/9/2019Patrick J. HaleyVPSell1,560$23.50$36,660.00  
1/8/2019Alan M GarberDirectorSell11,250$23.00$258,750.0072,579  
1/7/2019Patrick J. HaleyVPSell5,560$21.51$119,595.60  
1/4/2019Michael MorrisseyInsiderSell40,000$20.11$804,400.00  
1/3/2019Patrick J. HaleyVPSell8,000$19.95$159,600.00  
1/2/2019George A ScangosDirectorSell39,904$19.64$783,714.561,452,331  
1/2/2019Michael MorrisseyCEOSell6,046$20.00$120,920.00  
12/3/2018George A ScangosDirectorSell40,000$21.16$846,400.001,505,481  
12/3/2018Gisela SchwabInsiderSell13,499$21.02$283,748.98  
11/30/2018Christopher J. SennerCFOSell8,791$19.70$173,182.70  
11/30/2018Jeffrey HessekielEVPSell14,818$19.25$285,246.50  
11/29/2018George A ScangosDirectorSell6,500$20.00$130,000.001,505,481  
11/28/2018Jeffrey HessekielEVPSell11,759$19.12$224,832.08  
11/15/2018Michael MorrisseyInsiderSell25,000$17.22$430,500.00  
11/7/2018Patrick J. HaleyInsiderSell20,000$17.32$346,400.00  
11/2/2018Michael MorrisseyInsiderSell37,499$17.57$658,857.43  
11/1/2018George A ScangosDirectorSell25,000$14.66$366,500.001,521,981  
11/1/2018Gisela SchwabCMOSell12,000$14.16$169,920.00  
10/1/2018George A ScangosDirectorSell25,000$17.86$446,500.001,536,981  
10/1/2018Gisela SchwabInsiderSell12,000$17.77$213,240.00  
10/1/2018Michael MorrisseyCEOSell12,501$17.82$222,767.82  
9/24/2018George A ScangosDirectorSell25,000$16.85$421,250.001,561,981  
9/4/2018Gisela SchwabInsiderSell22,500$18.53$416,925.00  
8/20/2018Michael MorrisseyInsiderSell90,000$17.82$1,603,800.00  
8/15/2018Vincent T. MarchesiDirectorSell40,000$19.50$780,000.00  
8/9/2018Michael MorrisseyInsiderSell234,267$21.04$4,928,977.68  
8/7/2018Michael MorrisseyCEOSell100,000$21.10$2,110,000.00  
8/6/2018Patrick J. HaleyInsiderSell2,361$20.92$49,392.12  
8/1/2018Gisela SchwabInsiderSell22,500$20.56$462,600.00  
7/16/2018Michael MorrisseyInsiderSell90,000$21.13$1,901,700.00  
7/2/2018Gisela SchwabCMOSell22,500$21.20$477,000.00  
6/25/2018Michael MorrisseyInsiderSell90,000$19.62$1,765,800.00  
6/1/2018Gisela SchwabInsiderSell22,500$20.80$468,000.00  
5/31/2018Jeffrey HessekielEVPSell65,000$20.71$1,346,150.00  
5/30/2018Carl B FeldbaumDirectorSell34,262$20.60$705,797.2045,983  
5/24/2018Michael MorrisseyInsiderSell90,000$20.55$1,849,500.00  
5/22/2018Lance WillseyDirectorSell50,000$21.40$1,070,000.00418,273  
5/18/2018Patrick J. HaleyVPSell3,663$21.61$79,157.43  
5/11/2018Vincent T. MarchesiDirectorSell15,000$19.03$285,450.00  
5/9/2018Charles CohenDirectorSell15,000$21.42$321,300.00263,180  
5/7/2018Patrick J. HaleyInsiderSell27,549$22.17$610,761.33  
5/7/2018Stelios PapadopoulosDirectorSell15,000$22.15$332,250.00  
5/4/2018Jeffrey HessekielEVPSell20,000$22.36$447,200.00  
5/4/2018Patrick J. HaleyVPSell12,549$22.38$280,846.62  
5/3/2018Gisela SchwabCMOSell22,500$23.09$519,525.00  
4/16/2018Alan M GarberDirectorSell15,000$20.25$303,750.0076,329  
4/11/2018Michael MorrisseyInsiderSell90,000$20.78$1,870,200.00  
3/6/2018Vincent T. MarchesiDirectorSell15,000$24.73$370,950.00  
3/2/2018Lance WillseyDirectorSell30,000$23.91$717,300.00483,273  
2/28/2018George PosteDirectorSell15,000$26.26$393,900.00  
2/28/2018Patrick J. HaleyVPSell45,029$27.13$1,221,636.77  
See Full Table

SEC Filings (Institutional Ownership Changes) for Exelixis (NASDAQ:EXEL)

81.37% of Exelixis stock is owned by institutions. Institutional ownership can be a sign of analyst confidence in the fundamentals of the stock.

Institutional Buying and Selling by Quarter

Exelixis Institutional Trading History

Reporting DateHedge FundShares HeldMarket Value% of PortfolioQuarterly Change in SharesOwnership in Company
2/24/2021Virtu Financial LLC17,300$0.35M0.0%N/A0.006%
2/23/2021Principal Financial Group Inc.925,400$18.57M0.0%+0.3%0.297%
2/19/2021JPMorgan Chase & Co.11,662,211$234.06M0.0%+19.4%3.738%
2/19/2021AtonRa Partners103,080$2.07M1.0%N/A0.033%
2/19/2021Laffer Tengler Investments2,585$52K0.0%N/A0.001%
2/18/2021Truist Financial Corp45,097$0.91M0.0%+120.2%0.014%
2/17/2021Twinbeech Capital LP44,876$0.90M0.1%N/A0.014%
2/17/2021Canada Pension Plan Investment Board79,065$1.59M0.0%+47.3%0.025%
2/16/2021Squarepoint Ops LLC101,007$2.03M0.0%+71.1%0.033%
2/16/2021Morgan Stanley559,254$11.23M0.0%+52.3%0.180%
2/16/2021Mariner LLC20,474$0.41M0.0%+41.6%0.007%
2/16/2021Rice Hall James & Associates LLC105,099$2.11M0.1%-13.0%0.034%
2/16/2021Nuveen Asset Management LLC1,330,350$26.70M0.0%+5.4%0.429%
2/16/2021Colony Group LLC141,662$2.84M0.1%+2.9%0.046%
2/16/2021Guggenheim Capital LLC283,640$5.69M0.0%+13.5%0.091%
2/16/2021Price T Rowe Associates Inc. MD17,588,494$353M0.0%+28.9%5.669%
2/16/2021Amundi Pioneer Asset Management Inc.30,700$0.62M0.0%-3.6%0.010%
2/16/2021Virginia Retirement Systems ET AL84,800$1.70M0.0%+20.1%0.027%
2/16/2021Engineers Gate Manager LP51,624$1.04M0.0%+298.3%0.017%
2/16/2021Janus Henderson Group PLC874,031$17.54M0.0%-80.2%0.282%
2/16/2021Charles Schwab Investment Management Inc.1,535,772$30.82M0.0%+1.4%0.495%
2/13/2021American International Group Inc.561,129$11.26M0.0%-1.2%0.181%
2/13/2021Oak Associates Ltd. OH96,090$1.93M0.1%N/A0.031%
2/12/2021Stifel Financial Corp116,097$2.33M0.0%+11.7%0.037%
2/12/2021Federated Hermes Inc.100,864$2.02M0.0%-7.1%0.033%
2/12/2021LPL Financial LLC21,662$0.44M0.0%+4.0%0.007%
2/12/2021Amalgamated Bank49,614$1M0.0%+1.4%0.016%
2/12/2021Public Employees Retirement System of Ohio151,035$3.03M0.0%+25.4%0.049%
2/12/2021The Manufacturers Life Insurance Company 373,434$7.50M0.0%-7.8%0.120%
2/12/2021Nordea Investment Management AB293,973$5.90M0.0%+7.1%0.095%
2/12/2021Vontobel Holding Ltd.18,250$0.44M0.0%N/A0.006%
2/12/2021Virtus ETF Advisers LLC29,602$0.59M0.2%+13.4%0.010%
2/12/2021Regal Investment Advisors LLC31,731$0.64M0.1%N/A0.010%
2/12/2021Mercer Global Advisors Inc. ADV57,163$1.15M0.0%-10.6%0.018%
2/12/2021Twin Tree Management LP28,356$0.57M0.0%+642.9%0.009%
2/11/2021Lazard Asset Management LLC1,464,606$29.39M0.0%+24.7%0.472%
2/11/2021Fuller & Thaler Asset Management Inc.196,335$3.94M0.0%+8.4%0.063%
2/11/2021Trexquant Investment LP18,762$0.38M0.0%-75.8%0.006%
2/11/2021Northern Trust Corp2,407,516$48.32M0.0%-0.3%0.776%
2/11/2021Archer Investment Corp2,750$55K0.0%-26.7%0.001%
2/11/2021Burney Co.34,585$0.69M0.0%-80.7%0.011%
2/11/2021Teacher Retirement System of Texas28,188$0.57M0.0%+60.0%0.009%
2/11/2021Skandinaviska Enskilda Banken AB publ 129,400$2.60M0.0%-1.0%0.042%
2/11/2021Oppenheimer Asset Management Inc.42,939$0.86M0.0%-6.3%0.014%
2/10/2021Rhumbline Advisers838,989$16.84M0.0%-1.8%0.270%
2/10/2021Renaissance Technologies LLC21,682,651$435.17M0.5%-4.3%6.989%
2/10/2021Stephens Investment Management Group LLC1,409,846$28.30M0.4%-2.4%0.454%
2/10/2021TD Ameritrade Investment Management LLC3,140$63K0.0%N/A0.001%
2/10/2021Aviva PLC49,179$0.99M0.0%-44.8%0.016%
2/10/2021Panagora Asset Management Inc.133,574$2.68M0.0%-44.5%0.043%
2/10/2021HighTower Advisors LLC37,561$0.75M0.0%+9.2%0.012%
2/10/2021LS Investment Advisors LLC24,030$0.48M0.0%+5.4%0.008%
2/9/2021Wells Fargo & Company MN503,867$10.11M0.0%-8.9%0.162%
2/9/2021Hancock Whitney Corp120,251$2.41M0.1%-19.4%0.039%
2/9/2021Advisory Services Network LLC2,360$47K0.0%+164.0%0.001%
2/9/2021Duality Advisers LP72,022$1.45M0.1%N/A0.023%
2/9/2021Fiera Capital Corp2,559,450$51.37M0.1%-0.4%0.825%
2/9/2021STA Wealth Management LLC21,020$0.42M0.0%+109.3%0.007%
2/9/2021Seven Eight Capital LP82,300$1.65M0.4%N/A0.027%
2/9/2021Keybank National Association OH44,336$0.89M0.0%+35.7%0.014%
2/9/2021Donoghue Forlines LLC28,770$0.58M0.1%N/A0.009%
2/9/2021Bank of New York Mellon Corp3,110,785$62.43M0.0%-3.4%1.003%
2/9/2021Illinois Municipal Retirement Fund37,170$0.75M0.0%+80.3%0.012%
2/9/2021Oregon Public Employees Retirement Fund102,211$2.05M0.0%-1.9%0.033%
2/9/2021NBW Capital LLC47,322$0.95M0.3%-9.6%0.015%
2/9/2021Lord Abbett & CO. LLC411,200$8.25M0.0%-46.9%0.133%
2/9/2021Blair William & Co. IL1,557,786$31.27M0.1%-35.0%0.502%
2/9/2021Blume Capital Management Inc.3,712$75K0.0%+16.0%0.001%
2/9/2021ProShare Advisors LLC77,747$1.56M0.0%+2.3%0.025%
2/9/2021Profund Advisors LLC86,632$1.74M0.1%+8.3%0.028%
2/8/2021Alliancebernstein L.P.651,412$13.07M0.0%-8.2%0.210%
2/8/2021Principal Financial Group Inc.925,400$18.57M0.0%+0.3%0.298%
2/8/2021State Board of Administration of Florida Retirement System409,780$8.22M0.0%+6.0%0.132%
2/8/2021New York State Common Retirement Fund1,215,281$24.39M0.0%+3.4%0.392%
2/8/2021FIL Ltd530,182$10.64M0.0%+205.6%0.171%
2/8/2021Russell Investments Group Ltd.261,624$5.25M0.0%+28.8%0.084%
2/6/2021Pzena Investment Management LLC28,377$0.57M0.0%+36.3%0.009%
2/5/2021BlackRock Inc.31,387,574$629.95M0.0%+2.5%10.117%
2/5/2021Aperio Group LLC59,100$1.19M0.0%-15.0%0.019%
2/5/2021Swiss National Bank698,600$14.02M0.0%+0.5%0.225%
2/5/2021SG Americas Securities LLC175,609$3.52M0.0%+37.4%0.057%
2/5/2021US Bancorp DE31,253$0.63M0.0%+3.7%0.010%
2/5/2021Capital Management Corp VA267,556$5.37M1.5%+100.7%0.086%
2/4/2021Texas Permanent School Fund249,111$5M0.1%-16.9%0.080%
2/4/2021Cambridge Investment Research Advisors Inc.85,123$1.71M0.0%+21.8%0.027%
2/4/2021State of Wisconsin Investment Board322,717$6.48M0.0%-0.4%0.104%
2/4/2021Cambiar Investors LLC445,362$8.94M0.3%+35.6%0.144%
2/3/2021State of New Jersey Common Pension Fund D207,539$4.17M0.0%-5.4%0.067%
2/2/2021Treasurer of the State of North Carolina113,015$2.27M0.0%-20.2%0.036%
2/2/2021California Public Employees Retirement System754,189$15.14M0.0%+7.8%0.243%
2/2/2021First Trust Advisors LP3,349,143$67.22M0.1%-15.6%1.080%
2/1/2021NN Investment Partners Holdings N.V.90,300$1.81M0.0%+573.9%0.029%
2/1/2021State of Michigan Retirement System113,058$2.27M0.0%+0.4%0.036%
2/1/2021Tandem Capital Management Corp ADV15,420$0.31M0.2%+10.1%0.005%
2/1/2021Victory Capital Management Inc.207,946$4.17M0.0%-12.2%0.067%
2/1/2021Hussman Strategic Advisors Inc.102,500$2.06M0.5%+34.0%0.033%
2/1/2021Assenagon Asset Management S.A.2,208,308$44.32M0.2%N/A0.712%
1/30/2021Bender Robert & Associates85,545$1.72M0.5%-2.3%0.028%
1/29/2021Creative Planning119,159$2.39M0.0%+47.5%0.038%
1/28/2021Fieldpoint Private Securities LLC7,537$0.15M0.0%N/A0.002%
Data available starting January 2016

See Full Table
Exelixis logo
Exelixis, Inc., an oncology-focused biotechnology company, focuses on the discovery, development, and commercialization of new medicines to treat cancers in the United States. The company's products include CABOMETYX tablets for the treatment of patients with advanced renal cell carcinoma who received prior anti-angiogenic therapy; and COMETRIQ capsules for the treatment of patients with progressive and metastatic medullary thyroid cancer. Its CABOMETYX and COMETRIQ are derived from cabozantinib, an inhibitor of multiple tyrosine kinases, including MET, AXL, RET, and VEGF receptors. The company also offers COTELLIC, an inhibitor of MEK as a combination regimen to treat advanced melanoma; and MINNEBRO, an oral non-steroidal selective blocker of the mineralocorticoid receptor for the treatment of hypertension in Japan. In addition, Exelixis, Inc. is developing XL092, an oral tyrosine kinase inhibitor that targets VEGF receptors, MET, AXL, MER, and other kinases implicated in growth and spread of cancer. Exelixis, Inc. has research collaborations and license agreements with Ipsen Pharma SAS; Takeda Pharmaceutical Company Ltd.; F. Hoffmann-La Roche Ltd.; Redwood Bioscience, Inc.; R.P. Scherer Technologies, LLC; Catalent Pharma Solutions, Inc.; NBE Therapeutics AG; Aurigene Discovery Technologies Limited; Iconic Therapeutics, Inc.; Invenra, Inc.; StemSynergy Therapeutics, Inc.; Genentech, Inc.; GlaxoSmithKline; Bristol-Myers Squibb Company; and Daiichi Sankyo Company, Limited. The company was formerly known as Exelixis Pharmaceuticals, Inc. and changed its name to Exelixis, Inc. in February 2000. Exelixis, Inc. was founded in 1994 and is headquartered in Alameda, California.
Read More

Today's Range

Now: $22.66
$22.20
$22.84

50 Day Range

MA: $22.74
$21.32
$25.22

52 Week Range

Now: $22.66
$13.67
$27.80

Volume

1,409,643 shs

Average Volume

2,570,767 shs

Market Capitalization

$7.07 billion

P/E Ratio

47.21

Dividend Yield

N/A

Beta

1.21

Who are the company insiders with the largest holdings of Exelixis?

Exelixis' top insider shareholders include:
  1. George A Scangos (Director)
  2. Michael Morrissey (CEO)
  3. Vincent T Marchesi (Director)
  4. Lance Willsey (Director)
  5. Alan M Garber (Director)
  6. Carl B Feldbaum (Director)
  7. Charles Cohen (Director)
  8. Christopher J Senner (CFO)
  9. George Poste (Director)
  10. Gisela Schwab (CMO)
  11. Gisela Schwab (Insider)
  12. Jack L Wyszomierski (Director)
  13. Jeffrey Hessekiel (EVP)
  14. Michael Morrissey (Insider)
  15. Patrick J Haley (EVP)
  16. Patrick J Haley (Insider)
  17. Patrick J Haley (VP)
  18. Peter Lamb (EVP)
  19. Stelios Papadopoulos (Director)

Who are the major institutional investors of Exelixis?

Exelixis' top institutional investors include:
  1. BlackRock Inc. — 10.12%
  2. Renaissance Technologies LLC — 6.99%
  3. Price T Rowe Associates Inc. MD — 5.67%
  4. Meditor Group Ltd — 4.06%
  5. JPMorgan Chase & Co. — 3.74%
  6. First Trust Advisors LP — 1.08%

Which major investors are selling Exelixis stock?

During the previous quarter, EXEL stock was sold by these institutional investors:
  1. Janus Henderson Group PLC
  2. Renaissance Technologies LLC
  3. Blair William & Co. IL
  4. First Trust Advisors LP
  5. Chicago Capital LLC
  6. Lord Abbett & CO. LLC
  7. Meditor Group Ltd
  8. Burney Co.
Within the previous year, company insiders that have sold Exelixis company stock include:
  1. George A Scangos (Director)
  2. Michael Morrissey (CEO)
  3. Vincent T Marchesi (Director)
  4. Lance Willsey (Director)
  5. Alan M Garber (Director)
  6. Carl B Feldbaum (Director)
  7. Charles Cohen (Director)
  8. Christopher J Senner (CFO)
  9. George Poste (Director)
  10. Gisela Schwab (CMO)
  11. Gisela Schwab (Insider)
  12. Jack L Wyszomierski (Director)

Which major investors are buying Exelixis stock?

In the previous quarter, EXEL stock was acquired by institutional investors including:
  1. Price T Rowe Associates Inc. MD
  2. Assenagon Asset Management S.A.
  3. JPMorgan Chase & Co.
  4. Candriam Luxembourg S.C.A.
  5. BlackRock Inc.
  6. Scout Investments Inc.
  7. FIL Ltd
  8. Lazard Asset Management LLC
This undiscovered CBD play is on the verge of disrupting the industry
With recent health Canada approval they are poised to explode
Read more here